Scientific Publisher Sues Over Journal Pricing Study

Charging “unfair comparative advertising,” the scientific publishing firm of Gordon & Breach is suing the American Institute of Physics over an article and a letter about the costs of - professional journals that were published in the organization’s monthly magazine, Physics Today. The case raises numerous questions—in part because the New York-based publishing firm has so far chosen to press the case not in the United States, where Physics Today is published, but

Written byKen Kalfus
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Charging “unfair comparative advertising,” the scientific publishing firm of Gordon & Breach is suing the American Institute of Physics over an article and a letter about the costs of - professional journals that were published in the organization’s monthly magazine, Physics Today.

The case raises numerous questions—in part because the New York-based publishing firm has so far chosen to press the case not in the United States, where Physics Today is published, but in West Germany and Switzerland. Partisans for Physics Today charge that the lawsuits could inhibit scientific research, especially research about the explosive rise of journal prices (The Scientist, July 24, 1989, page 1); Gordon & Breach replies that the article is example of biased research performed by a scientist with a stake in the study’s result. The lawsuits, which seek injunctions, retractions, and damages, also raise questions about methods of comparing the costs of professional journals. Their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies